矿物甲类皮质体受体对抗剂促进脏免疫发生
Qiao-Rui Wang1, Yi Yang2,3
1Department of Nephrology, Center for Regeneration and Aging Medicine, the Fourth Affiliated Hospital of School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang, China.
International urology and nephrology
|April 30, 2025
概括
矿物皮质受体 (MR) 的激活驱动慢性病 (CKD) 的炎症. 非类固醇MR抗剂如finerenone通过调节免疫细胞转化和炎症来减少损伤.
科学领域:
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性病 (CKD) 与慢性炎症有关,部分原因是矿物质皮质醇受体 (MR) 激活.
- 免疫细胞失调在CKD中脏和心脏损伤的进展中起着关键作用.
研究的目的:
- 审查MR在CKD中免疫细胞调节中的作用.
- 探索MR抗剂 (MRAs),特别是芬,如何缓解脏和心脏损伤.
- 讨论MRAs对免疫细胞表型和炎症通路的影响.
主要方法:
- 文献综述侧重于CKD中免疫细胞的变化.
- 分析MR对巨细胞和T细胞两极分化的影响.
- 检查菲内伦的临床前抗炎和保护作用.
主要成果:
- 通过IL-14受体和MAPK-JNK,MR促进M1亲炎性巨细胞极化.
- MR增强T辅助细胞激活和IL-17/IL-23轴活性,同时抑制调节性T细胞.
- 临床前数据显示,finerenone可以减少炎症和脏损伤,而不会显著改变血压.
结论:
- 通过MR介导的免疫细胞变化对CKD相关的炎症和纤维化有显著的贡献.
- 菲内伦通过准这些免疫路径,显示出作为治疗剂的潜力.
- 对免疫机制和向治疗的进一步研究对于CKD治疗是有必要的.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
01:25Antihypertensive Drugs: Direct Renin Inhibitors
439
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
439
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
396
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
396
01:22Heart Failure Drugs: Diuretics
275
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
275
01:33Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
529
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
529